quinoxalines has been researched along with flavin mononucleotide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harkness, DR; Stadtman, ER | 1 |
| Aristoff, P; Batey, RT; Berman, J; Blount, KF; Coish, P; Gadwood, RC; Kaur, H; Kells, KW; Mondragón, E; Reyes, FE; Schostarez, HJ; Suto, RK; Vicens, Q; Wickens, P; Wilson, J | 1 |
2 other study(ies) available for quinoxalines and flavin mononucleotide
| Article | Year |
|---|---|
Bacterial degradation of riboflavin. VI. Enzymatic conversion of riboflavin to 1-ribityl-2,3-diketo-1,2,3,4-tetrahydro-6, 7-dimethylquinoxaline, urea, and carbon dioxide.
Topics: Ammonia; Biphenyl Compounds; Borates; Carbon Dioxide; Copper; Flavin Mononucleotide; Flavins; In Vitro Techniques; Kinetics; Mercury; Phenanthrolines; Pseudomonas; Quinoxalines; Riboflavin; Sulfites; Urea | 1965 |
Structure-Activity Relationship of Flavin Analogues That Target the Flavin Mononucleotide Riboswitch.
Topics: Anti-Bacterial Agents; Bacteria; Base Sequence; Binding Sites; Drug Design; Flavin Mononucleotide; Ligands; Molecular Structure; Quinoxalines; Riboswitch; RNA, Bacterial; Structure-Activity Relationship | 2018 |